1. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
   Dimitri Vanauberg et al, 2023, Oncogenesis CrossRef
2. Protein O‐GlcNAcylation: The sweet hub in liver metabolic flexibility from a (patho)physiological perspective
   Ya‐Jie Hu et al, 2024, Liver International CrossRef
3. Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN/APP axis as novel therapeutic strategies
   Liang-Yun Chen et al, 2024, Journal of Lipid Research CrossRef